PrenatalScreen® Standard
The PrenatalScreen® Standard test includes the analysis of a wide number of genes and the most common and clinically relevant diseases (740+ genes, 1000+ genetic conditions).
GeneSafe® De Novo
AutismScreen®
AutismScreen™ is the non-invasive genetic test that screens for autism spectrum disorders in children. The diagnosis of Autism Spectrum Syndromes is not simple and is made only on the basis of behavioral indicators. The AutismScreen ™ test can be a valuable aid for the early identification of a mutation related to a disease. The AutismScreen […]
CardioScreen® Prevention of Sudden Cardiac Arrest
CardioScreen-Prevenzione arresto cardiaco improvviso® is a diagnostic test that allows you to perform a multiple genetic analysis to investigate the presence of mutations associated with sudden cardiac death sine materia. The test identifies patients at genetic risk for potentially fatal cardiac events, through the analysis of their DNA.
Noonan, Costello, Leopard Syndromes – Panel
OncoNext™ Liquid Scan – 50 genes: Analysis of circulating tumor DNA (ctDNA)
OncoNext™ Tissue – 23 genes
OncoNext™ Liquid Scan – 23 genes: Analysis of circulating tumor DNA (ctDNA)
OncoNext™ Liquid Scan – 15 genes: Analysis of circulating tumor DNA (ctDNA)
OncoNext™ Liquid Monitor – Lung: Analysis of circulating tumor DNA (ctDNA)
Eurofins Genoma Group’s OncoNext ™ Liquid genetic tests were designed to study somatic mutations of circulating tumor DNA (ctDNA) in peripheral blood in patients with cancer or at high risk of cancer. The study of ctDNA, also called liquid biopsy, is the most innovative tool that the oncologist can use today. Thanks the OncoNext ™ […]